Pecato, Renneth L.

HRN: 23-58-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFUROXIME 500MG (TAB)
08/24/2023
08/31/2023
PO
500mg
BID X 7 Days
G1P0 36 2/7 Weeks AOG By LMP; Graves Disease, Impending Thyroid Storm; Preeclampsia Without Severe Features; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: